Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
2013
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
2011 Nobel
Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
2019
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium
2011
Head and neck squamous cell carcinoma
2020 Standout
T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
2013
Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells
2013
EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
2012
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
2003 StandoutNature
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells
2007
Molecular Biology of Barrett’s Adenocarcinoma
2001
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors
2013
Pancreatic cancer
2020 Standout
Immune Networks and Therapeutic Targeting of iNKT Cells in Cancer
2019
Wnt signaling in cancer
2016 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer
2016
Intestinal lineage commitment of embryonic stem cells
2010
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
PPAR influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
2004
Pancreatic cancer
2016 Standout
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma
2007
Esophageal Cancer
2003 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cancer stem cells revisited
2017 Standout
Hydrocarbons (jet fuel JP-8) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations
2013
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Intestinal Stem Cells
2010
Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease
2009
Targeted therapies in bladder cancer: an overview of in vivo research
2015
Dclk1 distinguishes between tumor and normal stem cells in the intestine
2012
Pancreatic Adenocarcinoma
2014 Standout
Every step of the way: integrins in cancer progression and metastasis
2018
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
2000
2-Oxoglutarate-dependent dioxygenases in cancer
2020 Nobel
DNA copy number profiling in esophageal Barrett adenocarcinoma:
2001
Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention
2001
PPARγ signaling exacerbates mammary gland tumor development
2004
Bladder cancer
2016 Standout
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
2009 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Mesothelin targeted cancer immunotherapy
2007
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
Targeting mutant p53 for efficient cancer therapy
2017
N-Glycoprotein SRMAtlas
2013
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas
2003
The hormone resistin links obesity to diabetes
2001 StandoutNature
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray
2003
Analysis of acute‐phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer
2011
Notch: Architect, Landscaper, and Guardian of the Intestine
2011 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Modeling Development and Disease with Organoids
2016 Standout
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase
2017 StandoutNobel
Hypoxia-inducible factor induces cysteine dioxygenase and promotes cysteine homeostasis in Caenorhabditis elegans
2023 StandoutNobel
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
2019
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
2008
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells
2010
Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases
2015 StandoutNobel
Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers
2007
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Rapamycin for longevity: opinion article
2019
Correlative imaging of ionic transport and electronic structure in nano Li0.5FePO4 electrodes
2019 StandoutNobel
Direct catalytic cross-coupling of alkenyllithium compounds
2014 StandoutNobel
One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength
2009
Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
2009
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial
2019
Identification of Novel Human CTL Epitopes and Their Agonist Epitopes of Mesothelin
2005
Chimeric Antigen Receptor Therapy
2018 Standout
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Critical role of NF-κB in pancreatic cancer
2014
Metabolic reprogramming and cancer progression
2020 StandoutScience
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
2010 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids
2013
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Clinical Application of Mass Spectrometry‐Based Proteomics in Lung Cancer Early Diagnosis
2020
Chemical Glycoproteomics
2016 StandoutNobel
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Stan Lightfoot being referenced
DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a miR-200a –Dependent Mechanism
2011
The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model
2010
Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer
2016
Inhibition of Pancreatic Intraepithelial Neoplasia Progression to Carcinoma by Nitric Oxide-Releasing Aspirin in p48Cre/+-LSL-KrasG12D/+ Mice
2012
Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway
2006
Expression of Peroxisome Proliferator Activated Receptor mRNA in Normal and Tumorigenic Rodent Mammary Glands
1998
Distinguishing Patients with Stage I Lung Cancer Versus Control Individuals using Serum Mass Profiling
2014
Oncogenic features of the JMJD2A histone demethylase in breast cancer
2012
Successful Treatment of Helicobacter Pylori-Negative Gastric MALT Lymphoma With Rituximab
2006
Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo
2008
Systemic molecular and cellular changes induced in rats upon inhalation of JP-8 petroleum fuel vapor
2010
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo
2011
Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease
2007
Biomarker Identification in Human Pancreatic Cancer Sera
2008
Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL‐KrasG12D/+ mice
2012
p53-stabilizing Agent CP-31398 Prevents Growth and Invasion of Urothelial Cancer of the Bladder in Transgenic UPII-SV40T Mice
2013
Expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus
1999
Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry
2011
Early Detection and Prevention of Pancreatic Cancer: Use of Genetically Engineered Mouse Models and advanced Imaging Technologies
2012
Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice
2015
Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.
2002
Doublecortin and CaM Kinase-like-1 and Leucine-Rich-Repeat-Containing G-Protein-Coupled Receptor Mark Quiescent and Cycling Intestinal Stem Cells, Respectively
2009
Therapeutic treatment of DMBA-induced mammary tumors with PPAR ligands.
2001
Loss of natural killer T cells promotes pancreatic cancer in LSL ‐KrasG12D/+ mice
2017
Abstract 4983: Intermittent dosing regimens of naproxen and aspirin inhibit azoxymethane-induced rat colon adenoma progression to adenocarcinoma and carcinoma invasion
2018
Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients
2017